Xcout IntelProPhase Labs, Inc. competitors & alternatives
The 12 closest competitors and alternatives to ProPhase Labs, Inc. among biotech companies — ranked by similarity to what ProPhase Labs, Inc. actually does, not by market-cap band.
Subscribe to see ProPhase Labs, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About ProPhase Labs, Inc.
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment provides crucial testing solutions, including PCR tests for SARS-CoV-2 (COVID-19) and its variant mutations, using both saliva and nasal swab collection methods. This segment also offers molecular testing for other respiratory pathogens and supplies personal genomics products and services. Additionally, ProPhase Labs extends its capabilities by providing comprehensive contract manufacturing services, covering product development, pre-commercialization activities, production, warehousing, and distribution. The company's diverse products and services reach consumers through a broad network of national chain drug stores, various regional retailers, and online platforms.
ProPhase Labs, Inc. at a glance
ProPhase Labs, Inc. is a biotech company headquartered in Uniondale, United States. It is publicly listed (PRPH) with a market capitalisation of $981,134. Xcout tracks 13 named people at ProPhase Labs, Inc., including Ted William Karkus (Chairman & Chief Executive Officer).
ProPhase Labs, Inc. leadership
- Ted William KarkusChairman & Chief Executive Officer
- Ted KarkusChairman & CEO
- Jason KarkusPresident of Nebula Genomics
- Kevin QuinnChief Product Officer of Nebula Genomics
- Ted KarkusExecutive Officer
- Carolina AbenanteDirector
7 more named people on record for ProPhase Labs, Inc., with roles, board committees and tenure — see the full roster →
Top 12 ProPhase Labs, Inc. competitors
Ranked by semantic similarity — how close each company is to ProPhase Labs, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology, Consumer Genetics, Healthcare
23andMe, Inc. is a leading consumer genetics and research company that helps people access, understand, and benefit from their genetic information. It offers DNA testing services for ancestry and health, and utilizes its crowdsourced genetic research platform for drug discovery programs across various disease areas.
Healthcare Diagnostics
Clear Health Pass Holdings LLC develops and provides advanced in-vitro diagnostic testing solutions, including saliva and fecal-based health diagnostic collections, genomics, and medical wellness testing. The company serves medical facilities, businesses, and government entities with diagnostic tools spanning areas such as cardiology, diabetes, genetics, women's health, allergies, and drug screening.
Similar biotech company
Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation panel designed to identify malignant thyroid nodules. Additionally, ThyraMIR evaluates thyroid nodules for malignancy risk through the application of its proprietary microRNA gene-expression assay. Furthermore, RespriDx is a genomic diagnostic tool that aids clinicians in distinguishing between metastatic and recurrent lung cancer. Interpace Biosciences further supports the pharmaceutical and biotechnology sectors with services including pharmacogenomics testing, genotyping, biorepository solutions, and various custom scientific offerings. Its clientele primarily consists of physicians, hospitals, and clinics. Previously operating as Interpace Diagnostics Group, Inc., the company adopted its current name, Interpace Biosciences, Inc., in November 2019. Founded in 1986, its corporate headquarters are located in Parsippany, New Jersey.
Similar biotech company
OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for disease detection, diagnosis, evaluation, monitoring, and treatment, covering areas such as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare. BioReference serves a diverse client base, including medical practices, clinics, hospitals, employers, and government entities. Additionally, this segment provides a cutting-edge diagnostic instrument system designed for immediate, point-of-care blood test results, alongside its specialized 4Kscore testing for prostate cancer. Within the Pharmaceutical segment, OPKO offers a range of therapeutic products and a robust development pipeline. Key offerings include Rayaldee, indicated for the management of secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease and vitamin D insufficiency. The pipeline features OPK88004, an investigational orally administered selective androgen receptor modulator; OPK88003, a peptide administered once weekly currently in Phase IIb trials for the treatment of type 2 diabetes and obesity; and hGH-CTP, a once-weekly human growth hormone injection that has successfully completed Phase III clinical trials in collaboration with Pfizer, Inc. A core strategy for this segment involves the development and commercialization of proprietary, extended-release versions of existing therapeutic proteins. Furthermore, OPKO Health supplies specialty active pharmaceutical ingredients (APIs) and is involved in the development, manufacturing, marketing, and sale of pharmaceutical, nutraceutical, veterinary, and ophthalmic products. The company also commercializes food supplements and over-the-counter products, produces and sells items primarily within the generics market, and handles the import, marketing, distribution, and sales of pharmaceutical products across various therapeutic areas, including cardiovascular conditions, vaccines, antibiotics, gastro-intestinal ailments, and hormone-related treatments, among others. Its pharmaceutical operations are further bolstered by platforms situated in Ireland, Chile, Spain, and Mexico. Founded in 1991, OPKO Health, Inc. maintains its corporate headquarters in Miami, Florida.
Biotechnology & Medical Laboratories
Access Genetics LLC operates a national reference laboratory that provides personalized diagnostics and molecular DNA testing services, including salivary diagnostics through its OralDNA Labs division. The company serves healthcare clients and patients by offering comprehensive diagnostic test options and clinical lab services.
Healthcare & Biotechnology
Incite Health Life Sciences, Inc. is a CLIA-certified and CAP-accredited high-complexity clinical laboratory that provides specialized diagnostic testing, including pharmacogenomics, infectious disease screening, and immune system monitoring. The company serves physicians, medical institutions, employers, and clinical trials by utilizing advanced methodologies and data-driven approaches to support early detection, disease monitoring, and personalized medicine.
Similar biotech company
Microbix Biosystems Inc. is a life science enterprise dedicated to advancing human health globally, including markets across North America and Europe. Established in 1988 and headquartered in Mississauga, Canada, the company specializes in developing and marketing unique biological and technological products. A significant part of its business involves producing essential biological reagents for the diagnostic industry. This encompasses antigens vital for immunoassays, alongside its distinctive Quality Assessment and Proficiency (QAP) products. These QAPs are instrumental for clinical laboratories, providing support for proficiency testing, the development and validation of diagnostic assays, and optimizing routine lab operations. Furthermore, Microbix applies its deep biological knowledge and infrastructure to create additional proprietary offerings. Among these are DxTM, a viral transport medium crucial for stabilizing patient specimens prior to laboratory analysis, and Kinlytic Urokinase, a biopharmaceutical thrombolytic drug employed to treat blood clots. The company channels its QAP sales to accreditation organizations, diagnostic companies, and clinical laboratories via an extensive network of regional distributors.
Similar biotech company
Dante Labs is a laboratory services and clinical genomics company headquartered in New York City, specializing in clinical whole genome sequencing and molecular diagnostics.
Medical Laboratories & Diagnostics
EBIEN Inc. operates a CLIA-certified clinical laboratory that provides advanced diagnostic testing services to healthcare providers, wellness clinics, and organizations. The company offers hormone, metabolic, nutritional, and genetic testing panels along with private-label solutions and educational resources to support personalized clinical care.
Similar biotech company
IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.
Healthcare and Diagnostics
Vivolabs is a clinical laboratory providing genetic testing, nutritional analysis, and diagnostic services for various health conditions.
Healthcare & Biotechnology
NxGen MDx is a privately held medical consulting and genetic screening company headquartered in Grand Rapids, Michigan, offering specialized laboratory and diagnostic testing services.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of ProPhase Labs, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for ProPhase Labs, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →